HealthQuant

REAL Physician Influence. Time to bring your KOL programming into the digital age! Tweets by @chimoose

[HealthQuant @HealthQuant]

Looking to find the perfect combination of strengths in KOLs and online influencers? Our latest blog post uncovers the secrets of multi-layered, segmented influencer lists. Stay tuned for expert insights! #KOL #MedAffairs #PharmaMarketing #MedTech https://t.co/8VDFRvfxGl

[HealthQuant @HealthQuant]

This could make things interesting - Viking's dosing protocols look like a promising differentiator from Lilly and Novo https://t.co/VcZoqvEq9f

[HealthQuant @HealthQuant]

It'll be interesting to see how Curium does head-to-head vs @Novartis - https://t.co/wMrW0UQ30F by @Nicole_DeFeudis via @endpts

[Petros Grivas @PGrivasMDPhD]

Fantastic meeting #IUCS26 @urologysummit led by @gbanna74 @ravikanesvaran international colleagues, great speakers @montypal @neerajaiims @DrYukselUrun @dr__mukherji @ProfSyedHussain @ParamMariappan @JimCatto @nataliagandur @OncoAlert @IBCG_BladderCA @BladderCancerUS @koshkin85

[HealthQuant @HealthQuant]

Love that @EliLillyandCo is creating an ecosystem around their flagship products: Eli Lilly invests in Oura to support patients on GLP-1 drugs https://t.co/enWFI2oxTt #pharma #feedly

[HealthQuant @HealthQuant]

This opens some potentially interesting doors: @Merck wins first approval of a PCSK9 cholesterol pill https://t.co/ZyBYxZZvBv #pharma #feedly

[HealthQuant @HealthQuant]

Do you remember when you joined X? I do! #MyXAnniversary

[Caribou Biosciences @CaribouBio]

If you’re in Stockholm for #EHA2026, check out Dr. Stephen Schuster’s presentation of our vispa-cel data to hear about long-term durability after a single dose of vispa-cel in patients with relapsed or refractory B cell non-Hodgkin lymphoma. #CellTherapy #CRISPR $CRBU

[Ankit Gupta @agupta]

really great to see @tamarindbio land a unique deal that i think may be a bellwether for more software in pharma

[HealthQuant @HealthQuant]

This could come in handy!

[Curiosity @MAstronomers]

If you ever get lost in the Milky Way galaxy, this is your map to get back to EARTH.

[LARVOL @Larvol]

Ahead of the @ASCO-2025, @Larvol CLIN spotlights the top companies driving the future of cancer research.

Get the latest #ASCO25 updates as they happen: https://t.co/051z3BNE4z

#LARVOL #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights | @ADesaiMD | @HHorinouchi | @DrRiyazShah | @FordePatrick | @lungoncdoc | @matteolambe | @ErikaHamilton9 | @PTarantinoMD | @DrChoueiri | @AndreaNecchi | @GillSharlene | @mtmdphd | @SuyogCancer

[HealthQuant @HealthQuant]

@tapshah21 Will do! Thank you, Tapan.

[HealthQuant @HealthQuant]

@tapshah21 Hi Tapan! Yesterday my app stopped returning user data when calling the X ID user endpoint. Nothing in the documentation implies that was intentionally deprecated; can you please help?

[HealthQuant @HealthQuant]

@isabelzam95 That's amazing - Congratulations!

[HealthQuant @HealthQuant]

PS I’ve had a Basic plan for a couple of years and have had no problems thus far …

[HealthQuant @HealthQuant]

@chrisparkX Chris, can you help me out? My app that makes API calls for user data based on Twitter ID stopped working yesterday. Documentation still says that should work w/my basic plan. Any ideas?

[HealthQuant @HealthQuant]

@XDevelopers It appears that you've changed the API endpoints for USER queries from the basic subscription. Can you confirm? That's not anywhere in the documentation.

[HealthQuant @HealthQuant]

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch. https://t.co/PEdqmhbDpi #pharma #feedly via @BioPharmaDive

[HealthQuant @HealthQuant]

This is one to watch: Startup led by John Maraganore raises $135M to build ‘future of RNAi’ https://t.co/u9wJjB31sR #pharma #feedly #biotech

[HealthQuant @HealthQuant]

2/2 But July, August and September of 2024 were each significantly higher than the same months in 2023. I'm encouraged that doctors are coming back. We'll keep watching! #MedTwitter #HCSM #HCSMEU

[HealthQuant @HealthQuant]

Interesting #MedTwitter stats: Comparing monthly twitter posts from global doctors, Posts from January-June of 2023 and 2024, physician posts were slightly down (February was actually up 2%). 1/2